Ultra-processed foods (UPFs ) account for a significant portion of energy intake in Western countries—in the United States, an estimated more than half. Given this ubiquity and a growing number of observational studies linking high UPF consumption to cardiometabolic diseases, the American Heart Association (AHA) issued its first comprehensive statement on the matter in 2025 in the form of a Science Advisory. The tone is noteworthy: The AHA carefully evaluates the evidence, warns against overinterpretation, and deliberately refrains from making blanket recommendations. For cardiologists and primary care physicians, it is worthwhile to understand this nuanced stance—precisely because the issue is often sensationalized in public discourse.
Publikation
- Ernährung/Adipositas-Special
Related Topics
You May Also Like
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Ischemic stroke: Are smaller or larger brain arteries affected?
Recent study findings on intravenous lysis therapy with fibrinolytic agents
- Interview
“On par with the gold standards for trauma”
- Psychology: Emotional Freedom Techniques (EFT)